insights_auto
Why is DRUG up ၇.၈၀%?
Dive Deeperchevron_right
DRUG:CNSX
Bright Minds Biosciences Inc
၇၆.၅၄ CA$
arrow_upward
+၇.၈၀%(+၅.၅၄) 1D
အောက် ၁၅, GMT-၄ ၁၆:၀၀:၀၀ · CAD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DRUG...
Open
၇၄.၈၉ CA$
High
၇၈.၄၅ CA$
Low
၇၃.၈၆ CA$
Mkt. cap
၇၅.၅၀ ကုဋေ
Avg. vol.
၈၆၈.၀၀
Volume
၉၄၂.၀၀
52-wk high
၁၇၀.၀၀ CA$
52-wk low
၆၈.၀၂ CA$
EPS
-၂.၉၀ CA$
No. of employees
၂၆
Open
၇၄.၈၉ CA$
High
၇၈.၄၅ CA$
Low
၇၃.၈၆ CA$
Mkt. cap
၇၅.၅၀ ကုဋေ
Avg. vol.
၈၆၈.၀၀
Volume
၉၄၂.၀၀
52-wk high
၁၇၀.၀၀ CA$
52-wk low
၆၈.၀၂ CA$
EPS
-၂.၉၀ CA$
No. of employees
၂၆
News stories
From web sources and news partners
MarketBeat
·
ပြီးခဲ့သည့် ၆ နာရီ
Bright Minds Biosciences (NASDAQ:DRUG) Stock Price Up 6.6% - Here's Why
Profile
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
About Bright Minds Biosciences Inc